232 related articles for article (PubMed ID: 33940114)
1. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan.
Hu TH; Su WW; Yang CC; Yang CC; Kuo WH; Chen YY; Yeh YH; Chen SS; Tsao YY; Chen KM; Yan SL; Lai JH; Yao CD; Lim CH; Jen HH; Yeh YP; Chen SL; Chen HH; Chen SC;
Am J Kidney Dis; 2021 Oct; 78(4):511-519.e1. PubMed ID: 33940114
[TBL] [Abstract][Full Text] [Related]
2. Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan.
Hu TH; Luh DL; Tsao YY; Lin TY; Chang CJ; Su WW; Yang CC; Yang CJ; Chen HP; Liao PY; Su SL; Chen LS; Hsiu-Hsi Chen T; Yeh YP;
Am J Gastroenterol; 2024 May; 119(5):883-892. PubMed ID: 38084857
[TBL] [Abstract][Full Text] [Related]
3. Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
Maduell F; Belmar L; Ugalde J; Laguno M; Martínez-Rebollar M; Ojeda R; Arias M; Rodas L; Rossi F; Llovet LP; González LN; Mallolas J; Londoño MC
Gastroenterol Hepatol; 2019 Mar; 42(3):164-170. PubMed ID: 30293914
[TBL] [Abstract][Full Text] [Related]
4. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
5. A new collaborative care approach toward hepatitis C elimination in marginalized populations.
Su WW; Yang CC; Chang RW; Yeh YH; Yen HH; Yang CC; Lee YL; Liu CE; Liang SY; Sung ML; Ko SY; Kuo CY; Chen SL; Yeh YP; Hu TH;
J Infect Public Health; 2023 Aug; 16(8):1201-1208. PubMed ID: 37271101
[TBL] [Abstract][Full Text] [Related]
6. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
[TBL] [Abstract][Full Text] [Related]
7. Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan - A multi-center collaborative care model.
Lo CC; Lei WY; Huang YC; Hwang JJ; Lo CY; Lin CH; Cheng HS; Liao YT; Liang PC; Chiou MJ; Bair MJ; Dai CY; Yu ML
J Microbiol Immunol Infect; 2023 Aug; 56(4):680-687. PubMed ID: 36822945
[TBL] [Abstract][Full Text] [Related]
8. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
[TBL] [Abstract][Full Text] [Related]
9. Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV survey.
Lin TY; Jen HH; Hu TH; Yao YC; Chen TH; Yen AM; Yeh YP
Hepatol Int; 2024 Apr; 18(2):476-485. PubMed ID: 37987951
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Hepatitis C Virus Infection in Dialysis Patients.
Kikuchi K
Contrib Nephrol; 2018; 196():119-122. PubMed ID: 30041215
[TBL] [Abstract][Full Text] [Related]
11. When and how can nephrologists treat hepatitis C virus infection in dialysis patients?
Davis MI; Chute DF; Chung RT; Sise ME
Semin Dial; 2018 Jan; 31(1):26-36. PubMed ID: 28925068
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C microelimination among people living with HIV in Taiwan.
Chen GJ; Ho SY; Su LH; Chang SY; Hsieh SM; Sheng WH; Liu WD; Huang YS; Lin KY; Chen YT; Su YC; Liu WC; Sun HY; Hung CC
Emerg Microbes Infect; 2022 Dec; 11(1):1664-1671. PubMed ID: 35608049
[TBL] [Abstract][Full Text] [Related]
13. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
14. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Chen CY; Huang CF; Cheng PN; Tseng KC; Lo CC; Kuo HT; Huang YH; Tai CM; Peng CY; Bair MJ; Chen CH; Yeh ML; Lin CL; Lin CY; Lee PL; Chong LW; Hung CH; Huang JF; Yang CC; Hu JT; Lin CW; Chen CT; Wang CC; Su WW; Hsieh TY; Lin CL; Tsai WL; Lee TH; Chen GY; Wang SJ; Chang CC; Mo LR; Yang SS; Wu WC; Huang CS; Hsiung CK; Kao CN; Tsai PC; Liu CH; Lee MH; Liu CJ; Dai CY; Kao JH; Chuang WL; Lin HC; Yu ML
Liver Int; 2021 Jun; 41(6):1265-1277. PubMed ID: 33655714
[TBL] [Abstract][Full Text] [Related]
16. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
Fabrizi F; Donato FM; Messa P
Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
[TBL] [Abstract][Full Text] [Related]
17. Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.
Wade AJ; McCormack A; Roder C; McDonald K; Davies M; Scott N; Wardrop M; Athan E; Hellard ME
J Viral Hepat; 2018 Sep; 25(9):1089-1098. PubMed ID: 29660212
[TBL] [Abstract][Full Text] [Related]
18. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
Manoj Kumar ; Nayak SL; Gupta E; Kataria A; Sarin SK
Liver Int; 2018 Dec; 38(12):2137-2148. PubMed ID: 29676846
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
[TBL] [Abstract][Full Text] [Related]
20. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
Fabrizi F; Lampertico P; Messa P
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
